Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Fish and Richardson
Teva
Healthtrust
Citi
Covington
Accenture
Colorcon
Johnson and Johnson

Generated: June 23, 2018

DrugPatentWatch Database Preview

Alkem Labs Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for ALKEM LABS LTD, and what generic and branded alternatives to ALKEM LABS LTD drugs are available?

ALKEM LABS LTD has thirty-four approved drugs.

There are seven tentative approvals on ALKEM LABS LTD drugs.

Summary for Alkem Labs Ltd
US Patents:0
Tradenames:31
Ingredients:31
NDAs:34

Drugs and US Patents for Alkem Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd LAMOTRIGINE lamotrigine TABLET;ORAL 200694-004 Jun 14, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN acetaminophen; tramadol hydrochloride TABLET;ORAL 202076-001 Mar 30, 2012 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd MYCOPHENOLATE MOFETIL mycophenolate mofetil TABLET;ORAL 091249-001 Nov 4, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 209042-002 Aug 14, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Moodys
Cerilliant
Deloitte
Johnson and Johnson
Fuji
Queensland Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.